IRADIMED CORPORATION Payments to Acquire Investments
IRADIMED CORPORATION (IRMD) reported Payments to Acquire Investments of $1.12 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2021-03-05
- IRADIMED CORPORATION payments to acquire investments for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- IRADIMED CORPORATION payments to acquire investments for the quarter ending 2018-09-30 was $206.09K.
- IRADIMED CORPORATION payments to acquire investments for the quarter ending 2017-12-31 was $1.37M, a 93.80% increase year-over-year.
- IRADIMED CORPORATION payments to acquire investments for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- IRADIMED CORPORATION payments to acquire investments for fiscal 2018 was $1.12M, a 58.25% decline from fiscal 2017.
- IRADIMED CORPORATION payments to acquire investments for fiscal 2017 was $2.69M, a 46.05% decline from fiscal 2016.
- IRADIMED CORPORATION payments to acquire investments for fiscal 2016 was $4.99M.
- IRADIMED CORPORATION payments to acquire investments for fiscal 2014 was $7.95M, a 159376.47% increase from fiscal 2013.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $206.09K derived: sum of 2 quarters · filed 2021-03-05 | $1.12M 10-K · filed 2021-03-05 | |
| 2018-09-30 | $206.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.12M 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $918.42K 10-Q · filed 2019-08-07 | |||
| 2017-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $1.37M derived: sum of 2 quarters · filed 2020-03-06 | $1.37M derived: sum of 3 quarters · filed 2020-03-06 | $2.69M 10-K · filed 2020-03-06 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $1.32M 10-Q · filed 2018-11-07 | $2.03M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $1.32M 10-Q · filed 2018-08-08 | $2.03M derived: sum of 3 quarters · filed 2019-03-07 | $3.55M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $1.32M 10-Q · filed 2018-05-08 | $2.03M derived: sum of 2 quarters · filed 2019-03-07 | $3.55M derived: sum of 3 quarters · filed 2019-03-07 | $5.59M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $708.18K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $2.23M derived: sum of 2 quarters · filed 2019-03-07 | $4.26M derived: sum of 3 quarters · filed 2019-03-07 | $4.99M 10-K · filed 2019-03-07 |
| 2016-09-30 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $3.56M derived: sum of 2 quarters · filed 2017-11-06 | $4.28M 10-Q · filed 2017-11-06 | |
| 2016-06-30 | $2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $2.76M 10-Q · filed 2017-08-04 | ||
| 2016-03-31 | $728.34K 10-Q · filed 2017-05-05 | |||
| 2014-12-31 | $7.95M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $7.95M derived: sum of 2 quarters · filed 2017-03-10 | $7.95M derived: sum of 3 quarters · filed 2017-03-10 | $7.95M 10-K · filed 2017-03-10 |
| 2014-09-30 | $471.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $1.77K derived: sum of 2 quarters · filed 2015-11-10 | $3.01K 10-Q · filed 2015-11-10 | $5.04K derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | $1.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $2.54K 10-Q · filed 2015-08-11 | $4.57K derived: sum of 3 quarters · filed 2015-08-11 | $5.53K derived: sum of 4 quarters · filed 2015-08-11 |
| 2014-03-31 | $1.24K 10-Q · filed 2015-05-11 | $3.27K derived: sum of 2 quarters · filed 2015-05-11 | $4.23K derived: sum of 3 quarters · filed 2015-05-11 | |
| 2013-12-31 | $2.03K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $2.99K derived: sum of 2 quarters · filed 2015-03-23 | $4.99K 10-K · filed 2015-03-23 | |
| 2013-09-30 | $962.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $2.96K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $2.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |